Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

HIGHLIGHTS

• who: Zhen Zhang from the Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany have published the paper: Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity, in the Journal: (JOURNAL)
• what: Taken together, our work highlights younger age but not TEM expansion or herpes virus immunity as a clinically relevant predictive factor for the onset of anti-PD-1 and amp; anti-CTLA4 related immune hepatitis.
• how: For patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.